Otasevic, V., Antic, D., MD, K. M., Cho, H., Lunney, N., Dabic, D., Learn, C. (2025). Risk of bleeding in chronic lymphocytic leukemia patients in remission treated with covalent Bruton tyrosine kinase inhibitors and contemporary anticoagulant or antiplatelet drugs: Real-world data analysis. Blood. https://doi.org/10.1182/blood-2025-6315